InsidersTradesSigma
Total declarations
Company
▲ Purchases (7 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
7
Disclosed sells
1
T+90 hit rate
50%
T+90 mean return
-10.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Lenk Robert P, Director. Director active across 1 company, notably Plus Therapeutics, INC.. In total, 8 filings have been published. Split: 7 buys · 1 sell. Total volume traded: €44k. History available since 13 September 2021. The latest transaction was filed on 8 May 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
4,167 shares@ US$2.0417.8% of flowCommon StockSEC:0000950170-24-057451:0
Canonical exit: 6 Aug 2024 (T+90)
1,000 shares@ US$1.773.7% of flowCommon StockSEC:0001209191-23-055638:0
Canonical exit: 13 Feb 2024 (T+90)
2,000 shares@ US$1.456.1% of flowCommon StockSEC:0001209191-23-055264:0
Canonical exit: 8 Feb 2024 (T+90)
5,000 shares@ US$1.6517.4% of flowCommon StockSEC:0001209191-23-054914:0
Canonical exit: 6 Feb 2024 (T+90)
1,395 shares@ US$1.504.4% of flowCommon StockSEC:0001209191-23-054650:0
Canonical exit: 4 Feb 2024 (T+90)
1,500 shares@ US$0.31471.0% of flowCommon StockSEC:0001209191-23-001447:0
7,000 shares@ US$1.85870.031% mcap50.0% of flowCommon StockSEC:0001209191-21-056096:0
Canonical exit: 12 Dec 2021 (T+90)
7,000 shares@ US$1.858724.8% of flowCommon StockSEC:0001209191-21-056096
Canonical exit: 12 Dec 2021 (T+90)
8 of 8 declarations
About Lenk Robert P
Robert P. Lenk serves as a Board Member at PLUS Therapeutics, Inc. In this role, he participates in the governance of the company, providing his expertise to assist in strategic decision-making. His experience in the biopharmaceutical sector allows him to contribute to the company's direction and performance improvement.
